IBDEI084 ; ; 09-FEB-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,174,0)
 ;;=DISCHARGE DAY VISIT^6^20
 ;;^UTILITY(U,$J,358.4,175,0)
 ;;=OTH NURSG FACILITY SVCS^4^20
 ;;^UTILITY(U,$J,358.4,176,0)
 ;;=TRANSITIONAL CARE^5^20
 ;;^UTILITY(U,$J,358.4,177,0)
 ;;=INPT VENT MGMT^2^21
 ;;^UTILITY(U,$J,358.4,178,0)
 ;;=ASSESSMENT^1^21
 ;;^UTILITY(U,$J,358.4,179,0)
 ;;=PROLONGED SERVICES^3^21
 ;;^UTILITY(U,$J,358.4,180,0)
 ;;=CARDIOVASCULAR^2^22
 ;;^UTILITY(U,$J,358.4,181,0)
 ;;=RESPIRATORY^15^22
 ;;^UTILITY(U,$J,358.4,182,0)
 ;;=MUSCULOSKELETAL^13^22
 ;;^UTILITY(U,$J,358.4,183,0)
 ;;=NEURO^14^22
 ;;^UTILITY(U,$J,358.4,184,0)
 ;;=GASTROENTEROLOGY^7^22
 ;;^UTILITY(U,$J,358.4,185,0)
 ;;=GENITOURINARY^8^22
 ;;^UTILITY(U,$J,358.4,186,0)
 ;;=HEMATOLOGY/ONCOLOGY^9^22
 ;;^UTILITY(U,$J,358.4,187,0)
 ;;=INJURY/TRAUMA^10^22
 ;;^UTILITY(U,$J,358.4,188,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^19^22
 ;;^UTILITY(U,$J,358.4,189,0)
 ;;=PAIN^15^22
 ;;^UTILITY(U,$J,358.4,190,0)
 ;;=COMPLICATIONS^3^22
 ;;^UTILITY(U,$J,358.4,191,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^4^22
 ;;^UTILITY(U,$J,358.4,192,0)
 ;;=V CODES^20^22
 ;;^UTILITY(U,$J,358.4,193,0)
 ;;=MASS^11^22
 ;;^UTILITY(U,$J,358.4,194,0)
 ;;=SCI^18^22
 ;;^UTILITY(U,$J,358.4,195,0)
 ;;=ALZHEIMERS^1^22
 ;;^UTILITY(U,$J,358.4,196,0)
 ;;=MEDICAL^12^22
 ;;^UTILITY(U,$J,358.4,197,0)
 ;;=PSYCHIATRIC^16^22
 ;;^UTILITY(U,$J,358.4,198,0)
 ;;=ENDOCRINE/METOBOLIC^5^22
 ;;^UTILITY(U,$J,358.4,199,0)
 ;;=ENT^6^22
 ;;^UTILITY(U,$J,358.4,200,0)
 ;;=INPATIENT ADMISSION VISIT^2^23
 ;;^UTILITY(U,$J,358.4,201,0)
 ;;=INPATIENT CONSULTS^1^23
 ;;^UTILITY(U,$J,358.4,202,0)
 ;;=INPATIENT SUBSEQUENT VISIT^3^23
 ;;^UTILITY(U,$J,358.4,203,0)
 ;;=DISCHARGE VISIT^4^23
 ;;^UTILITY(U,$J,358.4,204,0)
 ;;=OBSERVATION ADMISSION^5^23
 ;;^UTILITY(U,$J,358.4,205,0)
 ;;=OBSERVATION DISCHARGE^7^23
 ;;^UTILITY(U,$J,358.4,206,0)
 ;;=OBSERVATION SUBSEQUENT VISIT^6^23
 ;;^UTILITY(U,$J,358.4,207,0)
 ;;=CARDIAC^2^24
 ;;^UTILITY(U,$J,358.4,208,0)
 ;;=ENDOCRINE/METABOLIC^5^24
 ;;^UTILITY(U,$J,358.4,209,0)
 ;;=PULMONARY^20^24
 ;;^UTILITY(U,$J,358.4,210,0)
 ;;=EENT^4^24
 ;;^UTILITY(U,$J,358.4,211,0)
 ;;=MUSCULOSKELETAL^13^24
 ;;^UTILITY(U,$J,358.4,212,0)
 ;;=NEUROLOGIC^14^24
 ;;^UTILITY(U,$J,358.4,213,0)
 ;;=MENTAL HEALTH^12^24
 ;;^UTILITY(U,$J,358.4,214,0)
 ;;=GASTROENTEROLOGY^6^24
 ;;^UTILITY(U,$J,358.4,215,0)
 ;;=GU / RENAL^7^24
 ;;^UTILITY(U,$J,358.4,216,0)
 ;;=CANCER^3^24
 ;;^UTILITY(U,$J,358.4,217,0)
 ;;=HEMATOLOGIC & LYMPHATIC^8^24
 ;;^UTILITY(U,$J,358.4,218,0)
 ;;=INFECTIOUS DISEASE^10^24
 ;;^UTILITY(U,$J,358.4,219,0)
 ;;=SKIN^24^24
 ;;^UTILITY(U,$J,358.4,220,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^22^24
 ;;^UTILITY(U,$J,358.4,221,0)
 ;;=INTERSTITIAL LUNG DISEASE^11^24
 ;;^UTILITY(U,$J,358.4,222,0)
 ;;=PAIN^18^24
 ;;^UTILITY(U,$J,358.4,223,0)
 ;;=OTHER^17^24
 ;;^UTILITY(U,$J,358.4,224,0)
 ;;=COMMON PULMONARY DIAGNOSES^1^24
 ;;^UTILITY(U,$J,358.4,225,0)
 ;;=NEUROMUSCULAR/SKELETAL^15^24
 ;;^UTILITY(U,$J,358.4,226,0)
 ;;=OCCUPATIONAL^16^24
 ;;^UTILITY(U,$J,358.4,227,0)
 ;;=PLEURAL DISEASE^19^24
 ;;^UTILITY(U,$J,358.4,228,0)
 ;;=RADIATION^21^24
 ;;^UTILITY(U,$J,358.4,229,0)
 ;;=SKELETAL^23^24
 ;;^UTILITY(U,$J,358.4,230,0)
 ;;=HEPATIC & BILIARY^9^24
 ;;^UTILITY(U,$J,358.4,231,0)
 ;;=SUTURES/DRESSINGS^25^24
 ;;^UTILITY(U,$J,358.4,232,0)
 ;;=VASCULAR^26^24
 ;;^UTILITY(U,$J,358.4,233,0)
 ;;=BEDSIDE PROCEDURES^1^25
 ;;^UTILITY(U,$J,358.4,234,0)
 ;;=BLOODS,ARTERIAL & VENOUS^2^25
 ;;^UTILITY(U,$J,358.4,235,0)
 ;;=BRONCHOSCOPY^3^25
 ;;^UTILITY(U,$J,358.4,236,0)
 ;;=EXERCISE TESTING^4^25
 ;;^UTILITY(U,$J,358.4,237,0)
 ;;=OXIMETRY^6^25
 ;;^UTILITY(U,$J,358.4,238,0)
 ;;=PULMONARY FUCTION TESTING^7^25
 ;;^UTILITY(U,$J,358.4,239,0)
 ;;=RESPIRATORY THERAPY^8^25
 ;;^UTILITY(U,$J,358.4,240,0)
 ;;=THORACENTESIS^10^25
 ;;^UTILITY(U,$J,358.4,241,0)
 ;;=INTENSIVE CARE^5^25
 ;;^UTILITY(U,$J,358.4,242,0)
 ;;=TELE-HEALTH ICU^9^25
 ;;^UTILITY(U,$J,358.4,243,0)
 ;;=NEW PATIENT^2^26
 ;;^UTILITY(U,$J,358.4,244,0)
 ;;=ESTABLISHED PATIENT^1^26
 ;;^UTILITY(U,$J,358.4,245,0)
 ;;=CONSULTATIONS^3^26
 ;;^UTILITY(U,$J,358.4,246,0)
 ;;=BIOPSY/DEBRIDEMENT^1^27
 ;;^UTILITY(U,$J,358.4,247,0)
 ;;=I&D/ASPIRATION^10^27
 ;;^UTILITY(U,$J,358.4,248,0)
 ;;=DESTRUCT-BENIGN/PREMALIG LESIONS^3^27
 ;;^UTILITY(U,$J,358.4,249,0)
 ;;=PARING/CUTTING^16^27
 ;;^UTILITY(U,$J,358.4,250,0)
 ;;=EXCISE BENIGN-SCALP/NECK/HAND/GENITAL/FT^5^27
 ;;^UTILITY(U,$J,358.4,251,0)
 ;;=EXCISE BENIGN-FACE/EAR/NOSE/LIP/LID^4^27
 ;;^UTILITY(U,$J,358.4,252,0)
 ;;=EXCISION BENIGN-TRUNK/ARM/LEG^6^27
 ;;^UTILITY(U,$J,358.4,253,0)
 ;;=EXCISE MALIG-FACE/EAR/NOSE/LIP/LID^7^27
 ;;^UTILITY(U,$J,358.4,254,0)
 ;;=EXCISE MALIG-SCALP/NECK/HAND/GENITAL/FT^8^27
 ;;^UTILITY(U,$J,358.4,255,0)
 ;;=EXCISION MALIG-TRUNK/ARM/LEG^9^27
 ;;^UTILITY(U,$J,358.4,256,0)
 ;;=REPAIR,SIMPLE-SCALP/NECK/TRUNK/EXTREM^21^27
 ;;^UTILITY(U,$J,358.4,257,0)
 ;;=REPAIR,SIMPLE-FACE/EAR/NOSE/LID/LIP^20^27
 ;;^UTILITY(U,$J,358.4,258,0)
 ;;=REPAIR,INTERMED-SCALP/TRUNK/LEG/ARM^19^27
 ;;^UTILITY(U,$J,358.4,259,0)
 ;;=REPAIR,INTERMED-FACE/EAR/NOSE/LID/LIP^17^27
 ;;^UTILITY(U,$J,358.4,260,0)
 ;;=REPAIR,INTERMED-NECK/HAND/GENITAL/FT^18^27
 ;;^UTILITY(U,$J,358.4,261,0)
 ;;=REPAIR-SIMPLE WOUND DEHISCENCE^22^27
 ;;^UTILITY(U,$J,358.4,262,0)
 ;;=NURSING PROCEDURES^14^27
 ;;^UTILITY(U,$J,358.4,263,0)
 ;;=BLOOD^2^27
 ;;^UTILITY(U,$J,358.4,264,0)
 ;;=IV INFUSION^11^27
 ;;^UTILITY(U,$J,358.4,265,0)
 ;;=MEDICATION^12^27
 ;;^UTILITY(U,$J,358.4,266,0)
 ;;=MEDICATION ADMINISTATION^13^27
 ;;^UTILITY(U,$J,358.4,267,0)
 ;;=PARACENTESIS^15^27
 ;;^UTILITY(U,$J,358.4,268,0)
 ;;=OTHER^23^27
 ;;^UTILITY(U,$J,358.4,269,0)
 ;;=POST-OP COMPLICATIONS^16^28
 ;;^UTILITY(U,$J,358.4,270,0)
 ;;=GENERAL/SIGNS & SYMPTOMS^6^28
 ;;^UTILITY(U,$J,358.4,271,0)
 ;;=GYN/BREAST^8^28
 ;;^UTILITY(U,$J,358.4,272,0)
 ;;=MALE BREAST^10^28
 ;;^UTILITY(U,$J,358.4,273,0)
 ;;=BENIGN LESIONS OF SKIN^3^28
 ;;^UTILITY(U,$J,358.4,274,0)
 ;;=MALIGNANT LESIONS OF SKIN^11^28
 ;;^UTILITY(U,$J,358.4,275,0)
 ;;=MELANOMA^12^28
 ;;^UTILITY(U,$J,358.4,276,0)
 ;;=LACERATIONS^9^28
 ;;^UTILITY(U,$J,358.4,277,0)
 ;;=MERKEL CELL CANCER^13^28
 ;;^UTILITY(U,$J,358.4,278,0)
 ;;=AFTERCARE POST SURGERY^2^28
 ;;^UTILITY(U,$J,358.4,279,0)
 ;;=CARDIOVASCULAR^4^28
 ;;^UTILITY(U,$J,358.4,280,0)
 ;;=ENT^5^28
 ;;^UTILITY(U,$J,358.4,281,0)
 ;;=ABDOMINAL PAIN^1^28
 ;;^UTILITY(U,$J,358.4,282,0)
 ;;=GI^7^28
 ;;^UTILITY(U,$J,358.4,283,0)
 ;;=RESPIRATORY^17^28
 ;;^UTILITY(U,$J,358.4,284,0)
 ;;=ORTHOPEDIC^14^28
 ;;^UTILITY(U,$J,358.4,285,0)
 ;;=PLASTIC SURGERY^15^28
 ;;^UTILITY(U,$J,358.4,286,0)
 ;;=UROLOGY^18^28
 ;;^UTILITY(U,$J,358.4,287,0)
 ;;=NEW PATIENT^3^29
 ;;^UTILITY(U,$J,358.4,288,0)
 ;;=ESTABLISHED PATIENT^1^29
 ;;^UTILITY(U,$J,358.4,289,0)
 ;;=CONSULTATION^2^29
 ;;^UTILITY(U,$J,358.4,290,0)
 ;;=DEMENTIA^1^30
 ;;^UTILITY(U,$J,358.4,291,0)
 ;;=ALCOHOL INDUCED MENTAL DISORDERS^2^30
 ;;^UTILITY(U,$J,358.4,292,0)
 ;;=DRUG INDUCED MENTAL DISORDERS^3^30
 ;;^UTILITY(U,$J,358.4,293,0)
 ;;=OTHER MENTAL/NEURO DISORDERS^4^30
 ;;^UTILITY(U,$J,358.4,294,0)
 ;;=PERSISTENT MENTAL D/O-OTHER CONDITIONS^5^30
 ;;^UTILITY(U,$J,358.4,295,0)
 ;;=TRANSIENT MENTAL D/O-OTHER CONDITIONS^6^30
 ;;^UTILITY(U,$J,358.4,296,0)
 ;;=FUNCTIONAL BRAIN MAPPING^2^31
 ;;^UTILITY(U,$J,358.4,297,0)
 ;;=CNS ASSESSMENTS/TESTS^1^31
 ;;^UTILITY(U,$J,358.4,298,0)
 ;;=NEW PATIENT^2^32
 ;;^UTILITY(U,$J,358.4,299,0)
 ;;=ESTABLISHED PATIENT^1^32
 ;;^UTILITY(U,$J,358.4,300,0)
 ;;=CONSULTATIONS^3^32
 ;;^UTILITY(U,$J,358.4,301,0)
 ;;=POST-OP FOLLOW-UP^4^32
 ;;^UTILITY(U,$J,358.4,302,0)
 ;;=ABRASION w/o INFECTION^1^33
 ;;^UTILITY(U,$J,358.4,303,0)
 ;;=ABRASION w/ INFECTION^2^33
 ;;^UTILITY(U,$J,358.4,304,0)
 ;;=ABSCESS/CELLULITIS^3^33
 ;;^UTILITY(U,$J,358.4,305,0)
 ;;=ACNE^4^33
 ;;^UTILITY(U,$J,358.4,306,0)
 ;;=ALOPEICA^5^33
 ;;^UTILITY(U,$J,358.4,307,0)
 ;;=BURNS^6^33
 ;;^UTILITY(U,$J,358.4,308,0)
 ;;=CANDIDIASIS^7^33
 ;;^UTILITY(U,$J,358.4,309,0)
 ;;=CELLULITIS^8^33
 ;;^UTILITY(U,$J,358.4,310,0)
 ;;=DERMATITIS^9^33
 ;;^UTILITY(U,$J,358.4,311,0)
 ;;=DERMATOPHYTOSIS^10^33
 ;;^UTILITY(U,$J,358.4,312,0)
 ;;=ECZEMA^11^33
 ;;^UTILITY(U,$J,358.4,313,0)
 ;;=EDEMA^12^33
 ;;^UTILITY(U,$J,358.4,314,0)
 ;;=ERYTHEMA^13^33
 ;;^UTILITY(U,$J,358.4,315,0)
 ;;=EXPOSURE TO HEALTH HAZARDS^14^33
 ;;^UTILITY(U,$J,358.4,316,0)
 ;;=FOLLICULITIS^15^33
 ;;^UTILITY(U,$J,358.4,317,0)
 ;;=FURUNCLE^16^33
 ;;^UTILITY(U,$J,358.4,318,0)
 ;;=GRANULOMA^17^33
 ;;^UTILITY(U,$J,358.4,319,0)
 ;;=HERPES^35^33
 ;;^UTILITY(U,$J,358.4,320,0)
 ;;=HISTORY^36^33
 ;;^UTILITY(U,$J,358.4,321,0)
 ;;=ICHTHYOSIS^38^33
 ;;^UTILITY(U,$J,358.4,322,0)
 ;;=INSECT BITE w/o INFECTION^39^33
 ;;^UTILITY(U,$J,358.4,323,0)
 ;;=INSECT BITE w/INFECTION^40^33
 ;;^UTILITY(U,$J,358.4,324,0)
 ;;=KERATOSIS^42^33
 ;;^UTILITY(U,$J,358.4,325,0)
 ;;=LACERATION^44^33
 ;;^UTILITY(U,$J,358.4,326,0)
 ;;=LESION^46^33
 ;;^UTILITY(U,$J,358.4,327,0)
 ;;=LICHENIFICATION^47^33
 ;;^UTILITY(U,$J,358.4,328,0)
 ;;=LUPUS^48^33
 ;;^UTILITY(U,$J,358.4,329,0)
 ;;=MELANOMA^50^33
 ;;^UTILITY(U,$J,358.4,330,0)
 ;;=NAIL DISEASE^53^33
 ;;^UTILITY(U,$J,358.4,331,0)
 ;;=NEOPLASM-BENIGN^54^33
 ;;^UTILITY(U,$J,358.4,332,0)
 ;;=NEOPLASM-IN SITU^56^33
 ;;^UTILITY(U,$J,358.4,333,0)
 ;;=NEOPLASM-OTHER^57^33
 ;;^UTILITY(U,$J,358.4,334,0)
 ;;=NEURODERMATITIS^58^33
 ;;^UTILITY(U,$J,358.4,335,0)
 ;;=PEDICULOSIS^61^33
 ;;^UTILITY(U,$J,358.4,336,0)
 ;;=PITYRIASIS^62^33
 ;;^UTILITY(U,$J,358.4,337,0)
 ;;=PRURITUS^63^33
 ;;^UTILITY(U,$J,358.4,338,0)
 ;;=PSORIASIS^64^33
 ;;^UTILITY(U,$J,358.4,339,0)
 ;;=STASIS^66^33
 ;;^UTILITY(U,$J,358.4,340,0)
 ;;=ULCER^68^33
 ;;^UTILITY(U,$J,358.4,341,0)
 ;;=ULCER-LOWER EXTREMITY^69^33
 ;;^UTILITY(U,$J,358.4,342,0)
 ;;=URTICARIA^70^33
 ;;^UTILITY(U,$J,358.4,343,0)
 ;;=VARICOSE VEINS^71^33
 ;;^UTILITY(U,$J,358.4,344,0)
 ;;=WOUND^73^33
 ;;^UTILITY(U,$J,358.4,345,0)
 ;;="A" MISC DIAGNOSIS^5.1^33
 ;;^UTILITY(U,$J,358.4,346,0)
 ;;="B" MISC DIAGNOSIS^6.1^33
 ;;^UTILITY(U,$J,358.4,347,0)
 ;;="C" MISC DIAGNOSIS^8.1^33
